Company profile
Viveve Medical, Inc.
OTC: VIVE · Healthcare · Medical - Devices
#682 of 1,417 Healthcare companies by revenue63rd-percentile growth
EA Score
——FH —DQ 68GM —SS 51
v0.1 · 25/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ market scale, 3-yr revenue growth
Methodology →Revenue TTM
$6.8M
Rev growth YoY (TTM)
+2.4%
Net income (FY)
-$22.0M
Employees
47
as of 2026-07-12
Market cap
$2.1k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.4M$6.4M2021
Net income-$22.0M-$22.0M2021
Operating income-$21.6M-$21.6M2021
Total assets$25.9M$25.9M2021
Liabilities$10.8M$10.8M2021
Equity$15.1M$15.1M2021
Revenue trend
FY2014 – FY2021 · USD
FY14
FY15
FY16
FY18
FY18
FY19
FY20
FY21
Revenue by segment
Filed disclosures · FY2021
By product
Rental100%
By geography
UNITED STATES58%
Asia Pacific41%
CANADA1%
Europe And Middle East0%
Latin America0%
The read
What is Viveve Medical, Inc.’s revenue?
Viveve Medical, Inc. booked $6.4M in FY2021 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -342.8% net margin.
Peers · Healthcare
Encision Inc.——GlobeImmune, Inc.——Kyntra Bio, Inc.60CKorro Bio, Inc.41DHTG Molecular Diagnostics, Inc.——Jack Nathan Medical Corp.——Neighbors
Arapahoe →Key facts
CEOScott D. Durbin
SectorHealthcare
IndustryMedical - Devices
HeadquartersEnglewood, CO
ExchangeOTC: VIVE
Employees47
IPO date1992-03-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.